Sequence Similarity Clusters for the Entities in PDB 6IAP

Entity #1 | Chains: A
Natural cytotoxicity triggering receptor 1 protein, length: 182 (BLAST)
Sequence Similarity Cutoff Rank Chains in Cluster Cluster ID / Name Structural variation in cluster
100 % 2 2 55612
95 % 2 2 41779 Flexibility: Low
Max RMSD: 1.6, Avg RMSD: 1.6
PDBFlex
90 % 2 2 39731
70 % 2 2 35224
50 % 2 2 24910
40 % 2 2 20962
30 % 27 39 1200
Entity #2 | Chains: D
Fab NKp46-4 light chain protein, length: 211 (BLAST)
Sequence Similarity Cutoff Rank Chains in Cluster Cluster ID / Name
100 % 1 1 78321
95 % 1 1 47614
90 % 311 530 4
70 % 1494 2367 2
50 % 1866 3002 2
40 % 1866 3002 2
30 % 3790 6093 1
Entity #3 | Chains: E
Fab NKp46-4 heavy chain protein, length: 217 (BLAST)
Sequence Similarity Cutoff Rank Chains in Cluster Cluster ID / Name
100 % 1 1 83564
95 % 1 1 58595
90 % 1 1 55318
70 % 1804 2902 1
50 % 1899 3034 1
40 % 1899 3047 1
30 % 3791 6093 1
Entity #4 | Chains: H
Fab NKp46-1 heavy chain protein, length: 220 (BLAST)
Sequence Similarity Cutoff Rank Chains in Cluster Cluster ID / Name Structural variation in cluster
100 % 1 1 65120
95 % 2 2 39338 Flexibility: Low
Max RMSD: 1.1, Avg RMSD: 1.1
PDBFlex
90 % 2 2 33719
70 % 1805 2902 1
50 % 1900 3034 1
40 % 1900 3047 1
30 % 3792 6093 1
Entity #5 | Chains: L
Fab NKp46-1 light chain protein, length: 211 (BLAST)
Sequence Similarity Cutoff Rank Chains in Cluster Cluster ID / Name Structural variation in cluster
100 % 2 2 45050
95 % 9 10 5402 Flexibility: Low
Max RMSD: 7.7, Avg RMSD: 2.3
PDBFlex
90 % 312 530 4
70 % 1495 2367 2
50 % 1867 3002 2
40 % 1867 3002 2
30 % 3793 6093 1

Instructions

In the table for each entity, view a list of similar sequences by selecting the link associated with the percentage cutoff.



View more detailed documentation on the redundancy reduction and sequence clustering procedure used by RCSB PDB.

You can also use the structure comparison tool to compare any 2 given structures


ACTION - (A) Select for download / view details OR (B) Select two chains for comparison
Rank PDB ID Entity ID Chains Description Details Taxonomy EC Number
1 4NZU 1 L 13PL heavy chain Fab 9606
2 5TY6 2 L VRC 315 13-1b02 Fab Light chain 9606
3 6MEE 2 B, D antibody HEPC74 Light Chain 9606
4 5UCB 2 L Fab Light Chain 9606
5 5I8C 2 B VRC34.01 Fab light chain 9606
6 5WK2 1 L M116 LIGHT CHAIN 9606
7 4HS6 2 A, L MRCT10.v362 Fab light chain 9606
8 5VSI 2 L CH1/Ckappa Fab light chain 9606
9 6AZM 1 A, C 580 germline antibody, light chain Fragment: Fab 9606
10 4NWU 2 L APE1551 Ab Fab light chain 9606
11 3HC4 2 L IMMUNOGLOBULIN IGG1 FAB, LIGHT CHAIN 9606
12 5OB5 3 L fAb Light chain 9606
13 5UEA 3 B, L Fab Light Chain 9606
14 5TDN 1 A, C anti-HER2 Fab Light Chain 9606
15 3NCJ 1 L Fab15 Mut8 light chain 9606
16 3HC3 2 L IMMUNOGLOBULIN IGG1 FAB, HEAVY CHAIN 9606
17 4NWT 1 L APE1531 Ab Fab light chain 9606
18 3NA9 1 L Fab15 light chain 9606
19 5U6A 1 A Light Chain 9606
20 5UEK 3 L Fab 12E Light Chain 9606
21 3NAA 1 L Fab15 Mut5 light chain 9606
22 5IK3 2 B, D 1E03 Fab fragment light chain 9606
23 5U3D 1 A MEMAB TRASTUZUMAB FAB LIGHT CHAIN I83E 9606
24 6BHZ 2 L, M Trastuzumab Anti-HER2 Fab Light Chain D185A 9606
25 5IT2 2 L light chain 9606
26 6MY4 2 B, L anti-VEGF-A Fab fragment bH1 light chain 9606
27 6DW2 1 A 6078 Fab light chain 9606
28 6BQB 1 L MGG4 Fab light chain 9606
29 4PUB 2 L DX-2930 LIGHT CHAIN 9606
30 6B14 2 L Light chain of Fab BL3-6S97N 10090
31 5VKD 3 L Fab light chain 9606
32 5XHG 1 A, C polypeptide(L) 10090
33 3OAZ 2 K, L Fab 2G12, light chain 9606
34 6OTC 3 L sFab H3 light chain 32630
35 6MY5 2 B, L anti-VEGF-A Fab fragment bH1 light chain 9606
36 5U4R 2 B, L VRC 315 53-1A09 Fab Light chain 9606
37 5U5F 1 A MEMAB TRASTUZUMAB FAB LIGHT CHAIN I83E 9606
38 6BI2 2 L, M Trastuzumab Anti-HER2 Fab Light Chain 9606
39 4JHA 2 L D25 light chain 9606
40 6B9Z 1 A Trastuzumab Fab light chain 10090
41 5KVL 2 L Humanized 10G4 anti-Leukotriene C4 Immunoglobulin G (IgG) light chain 9606
42 5TDO 1 A, C anti-HER2 Fab Light Chain 9606
43 6PE7 2 L FAB Light chain 9606
44 5D6C 1 A, L 4497 antibody IgK (VL and CL) 9606
45 6IAS 2 L Fab NKp46-1 light chain 32630
46 6OBZ 2 B, L Light chain of FluA-20 Fab, Immunoglobulin light chain 9606
47 3P0Y 3 L Fab DL11 light chain 9606
48 6ANA 3 L LL2 Fab Light Chain 10090
49 6AOD 1 A FXIa Antibody FAB Light Chain 9606
50 6ELE 2 B, L fAB light chain 9606
51 5UR8 2 B human immunoglobulin gamma, kappa light chain 9606
52 3NAC 1 L Fab15 Mut7 light chain 9606
53 5U5M 1 A MEMAB TRASTUZUMAB, LIGHT CHAIN 9606
54 3EO9 1 L Efalizumab Fab fragment, light chain 9606
55 6N35 1 K, L Fab 2G12 light chain 9606
56 5WUV 1 L light chain 9606
57 2HWZ 1 L Immunoglobulin Fab light chain Humanized mouse antibody MEDI-493 Anti-respiratory syncytial virus antibody 10090
58 5TDP 1 A, C anti-HER2 Fab Light Chain 9606
59 6BAH 1 A Trastuzumab Fab light chain,Immunoglobulin kappa constant 10090
60 6D0X 2 B 1210 Antibody, light chain 9606
61 1L7I 1 L chimera of Fab2C4: "humanized" murine monoclonal antibody The chimera consists of the human Ig and the original murine sequence light chain (residues 1-214) 9606
62 1JPT 1 L immunoglobulin Fab D3h44, light chain Fab fragment 9606
63 6O39 1 A Antibody F2.I Fab, Light chain 9606
64 5XKU 2 B HNIgGA6 light chain 9606
65 6MTT 1 L Antibody VRC46.01 Fb light chain 9606
66 5I18 1 L FAB LIGHT CHAIN 9606
67 3SOB 1 L antibody light chain 9606
68 6B5M 2 L CIS43 Fab Light chain 9606
69 4G6M 3 L light chain of gevokizumab antibody binding fragment 10090
70 4KQ3 1 L CNTO3186 light chain Fab 9606
71 2VXQ 3 L FAB L CHAIN OF THE FAB FRAGMENT COMPOSED OF THE IGE VARIABLE DOMAIN AND IGG CONSTANT DOMAIN 9606
72 4I77 2 L Lebrikizumab light chain Fab 9606
73 5WK3 1 P, R, T, V M116 LIGHT CHAIN 9606
74 4HJG 1 A Trastuzumab light chain 9606
75 3HC0 2 B, L IMMUNOGLOBULIN IGG1 FAB, HEAVY CHAIN 9606
76 5NYX 2 L, N, P LIGHT CHAIN fab light chain 9606
77 5IFA 2 L VRC01c-HuGL2 Fab light chain 9606
78 6ELJ 2 B, L fAB light chain 9606
79 4G6K 2 L light chain of gevokizumab antibody binding fragment 10090
80 1JPS 1 L immunoglobulin Fab D3H44, light chain Fab fragment 9606
81 6CBV 2 L Light Chain, Fab fragment 9606
82 5JW5 2 B, L MEDI8852 Light chain 9606
83 6DCV 1 A, L Light chain of CBTAU27.1 Fab 9606
84 3QWO 1 B, L motavizumab light chain 10090
85 4IOI 1 A Trastuzumab light chain 9606
86 5K8A 1 A, E, L, M humanized Fab Lite chain 10090
87 5VAG 2 B Light chain of antibody m826 9606
88 4RBP 1 K, L Fab 2G12 light chain 9606
89 6DCW 1 L Light chain of CBTAU27.1 Fab 9606
90 6B5N 2 L CIS43 Fab Light chain 9606
91 3OAY 1 K, L Fab 2G12, light chain 9606
92 6AND 3 L Pinatuzumab Fab light chain 9606
93 5JRP 1 L marberg virus monoclonal antibody MR78 Fab light chain 9606
94 5F7E 2 L Fab light chain 9606
95 1T3F 1 A Huzaf antibody light chain The source is engineered human constant and framework regions with CDRs from mouse 9606
96 5FHA 2 L Antibody 114 Fab light chain 9606
97 5UMN 3 D, F Antibody C05, light chain 9606
98 4X7S 2 L Ig kappa chain C region residues 23-236 9606
99 1S3K 1 L HU3S193 Fab fragment, light chain murine complementarity determining regions grafted onto human framework and constant sequences 10090
100 3QPQ 1 C, E, I, L C1068 light chain 10090
101 6PHB 2 A, C 2530 Antibody Fab, Light Chain 9606
102 6MXR 2 B, L anti-VEGF-A Fab fragment bH1 light chain 9606
103 6ELL 2 B, L fAB light chain 9606
104 2HFF 1 A, L CB2 Fab, light chain 9606
105 4M7K 1 L 10H10 light chain SEE REMARK 999 10090
106 1VGE 1 L TR1.9 FAB FAB FRAGMENT OF A HUMAN IGG1 KAPPA AUTOANTIBODY 9606
107 6MXS 2 B, L anti-VEGF-A Fab fragment bH1 light chain 9606
108 5I1L 1 A, L FAB LIGHT CHAIN 9606
109 5GGV 1 L light chain 9606
110 3L5X 1 L H2L6 LIGHT CHAIN 9606
111 5BJZ 3 H, L Synthetic antibody, Fab fragment, Light Chain 9606
112 2R8S 2 L Fab light chain 10090
113 4HKZ 1 A Trastuzumab light chain 9606
114 6DB8 3 L Fab-Light chain 32630
115 6DDR 1 A Anti-MICA Fab fragment light chain clone 13A9 10090
116 6MEH 3 L antibody HEPC74 Light Chain 9606
117 3OAU 2 L Fab 2G12, light chain 9606
118 5WEQ 1 A MR78 mutant light chain 9606
119 4ZYK 2 B, L AM14 light chain 9606
120 6DWA 1 A, L 4497 Fab Light Chain 9606
121 5E94 1 A, C Antibody Fab fragment light chain 10090
122 6MED 2 B, D, I antibody HEPC3 Light Chain 9606
123 1CE1 1 L PROTEIN (CAMPATH-1H:LIGHT CHAIN) FAB 9606
124 6ME1 2 B, D VRC34.01 Fab light chain 9606
125 5ITB 2 L anti-RSV F Fab 14N4 Light chain 9606
126 4KMT 1 L light chain O12/KAPPA Fab 9606
127 6CW3 2 B, D antibody light chain 9606
128 6BTJ 2 B, L Light chain of H7.5 Fab 9606
129 6BLI 2 B, E, H, K CB002.5 Fab Light Chain 9606
130 4XTR 3 D, F Antibody Light chain 32630
131 1RZ7 1 L Fab 48d light chain 9606
132 1RZG 2 B, D Fab 412d heavy chain 9606
133 5EA0 2 L Light chain of antibody 7968 Fab fragment 9606
134 3PGF 3 L SAB Light Chain 9606
135 6B9Y 1 A Trastuzumab Fab light chain 9606
136 2QQN 3 L Antibody light chain 9606
137 6MSY 1 L Fab 2G12, light chain 9606
138 3L5W 1 A, L C836 LIGHT CHAIN CHIMERIC MOLECULE OF MOUSE VARIABLE DOMAIN AND HUMAN CONSTANT DOMAIN 10090
139 6BAE 1 A Trastuzumab Fab light chain 10090
140 4OGY 3 L, N DX-2930 LIGHT CHAIN 9606
141 2CMR 3 L D5 9606
142 5ZV3 3 L Light chain (kappa) of antibody CBTAU28.1 9606
143 4R4B 1 A, C, E, L FAB 2.2C LIGHT CHAIN 9606
144 5CZX 3 D, L 20358 Fab light chain 9606
145 6BI0 2 L, M Trastuzumab anti-HER2 Fab Light Chain 9606
146 3GRW 2 L Fab light chain 9606
147 6B3K 2 L Light chain of Fab BL3-6 10090
148 5I1D 1 A, L FAB LIGHT CHAIN 9606
149 5VKK 2 B, L Epratuzumab Fab Light Chain 10090
150 6AYZ 2 C, D Fab Light Chain 9606
151 6O3A 1 A Antibody F7.B Fab, Light chain 9606
152 1UJ3 1 A IgG Fab light chain anti-tissue-factor antibody hATR-5 Fab 9606
153 4LKC 1 A Fab fragment of PCSK9 antibody 9606
154 4KZD 2 L BL3-6 Fab antibody, light chain 10090
155 4CNI 2 B, L OLOKIZUMAB LIGHT CHAIN, FAB PORTION FAB PORTION 9606
156 6O1F 4 L Light Chain hu31A.v11 9606
157 4XH2 2 B, D, F, I, K, L Fab Light Chain 9606
158 5IES 2 L VRC01cHuGL2 Fab light chain 9606
159 6OCB 2 L Light chain of FluA-20 Fab 9606
160 6RCS 2 B R5.016 light chain 9606
161 3S34 1 L 1121B Fab light chain 10090
162 6B6Z 1 A, C Apo Fab Light Chain 9606
163 6EMJ 2 B, L fAb light chain 9606
164 5W1G 2 L CR1-07 Fab light chain 9606
165 6CNR 1 L Aducanumab light chain 9606
166 6OKM 2 L Fab 3C8 light chain 9606
167 3PNW 1 A, D, G, J, M, P, S, V FAB light chain 32630
168 4NRX 3 B, E, L m66 Light Chain 9606
169 3O2D 1 L ibalizumab light chain 10090
170 6DB9 3 L Fab-Light-Chain 32630
171 3HI6 3 L, Y light chain of Fab fragment of AL-57 against alpha L I domain 9606
172 5O14 3 D, L Fab 1A12 Light Chain 9606
173 4ZFG 3 L Fragment antigen binding 5A12 light chain 9606
174 6B5O 2 L CIS43 Fab Light chain 9606
175 2R0L 1 L antibody light chain 32630
176 5BK1 2 D, L Synthetic antibody, Fab fragment, Light Chain 9606
177 6N32 1 L, M Fab 2G12 light chain 9606
178 6TYB 4 L NEUTRALIZING ANTIBODY ITS90.03 FAB LIGHT CHAIN 9544
179 6DWC 1 A, L 4497 Fab Light Chain 9606
180 5VR9 2 B, L CH1/Ckappa Fab light chain 9606
181 5VZ1 1 A, C Apo Antibody Fab Light Chain 9606
182 5OD8 2 B B2 Fab fragment - Light chain 9606
183 3KR3 3 L antibody-Fab (light chain) 9606
184 6DZN 1 L Antibody ADI-15878, light chain 9606
185 5GGU 2 B, L light chain 9606
186 5KW9 3 L IgA Light chain 9606
187 5W2B 2 L Fab Light Chain 9606
188 6E4X 2 Y S5V2-29 light chain 9606
189 3C08 1 L Matuzumab Fab Light chain Human/mouse chimeric derivative of mouse monoclonal antibody 425 10090
190 6AXL 1 B, C Fab317 light chains 9606
191 6HIG 2 L Light Chain 10090
192 6CXG 1 K, L anti-HIV-1 Fab 2G12 light chain 9606
193 6CO3 1 L Fab light chain 9606
194 4NRZ 2 B, L M66.6 LIGHT CHAIN Fab Light Chain 9606
195 3BN9 2 C, E E2 Fab Light Chain 9606
196 6DZR 2 L h38c2 light chain 9606
197 6DF0 1 L 4G10-4D5 Antibody Light chain 32630
198 6DF1 1 L Anti-phosphotyrosine antibody 4G10-4D5 heavy chain 9606
199 3L95 1 A, L anti-NRR1 fab fragment light chain 9606
200 4OGX 3 L DX-2930 LIGHT CHAIN 9606
201 4KZE 2 L BL3-6 Fab antibody, light chain 10090
202 6MU3 1 K, L Fab 2G12, light chain 9606
203 4XVU 3 D, F, J, L Antibody light chain 32630
204 5B71 1 A, C SKY59 Fab light chain 9606
205 6BF4 3 C, L VRC-PG05 Fab light chain 9606
206 3NAB 1 L Fab15 Mut6 light chain 9606
207 4Q9Q 2 L Fab BL3-6, LIGHT CHAIN 10090
208 4WV1 3 A, D Fab light chain 9606
209 5EII 2 B, L Fab Light Chain 9606
210 4FNL 2 L, M Antibody C05, Light Chain 9606
211 4UB0 2 L IgG1, light chain 9606
212 1FVD 1 A, C IGG1-KAPPA 4D5 FAB (LIGHT CHAIN) 9606
213 1BJ1 1 J, L Fab fragment, light chain HUMANIZED VERSION OF A MONOCLONAL MURINE ANTI-VEGF ANTIBODY 10090
214 6BFT 1 B, L Avastin Light Chain Fab fragment mutant 9606
215 3IDX 3 L Fab b13 light chain 9606
216 5IF0 2 B, L VRC01c-HuGL2 Fab light chain 9606
217 4K94 1 L Fab19 heavy chain 9606
218 5K9Q 4 I, K, L, T, V, Y 16.a.26 Light chain 9606
219 6B5L 2 L CIS43 Fab Light Chain 9606
220 4ZD3 2 L 679-14-14E06 Fab fragment light chain 9606
221 5VEB 2 B, L anti-CDH6 Fab light chain 9606
222 6N81 2 D, L A1227 Fab light chain 9606
223 5E08 2 L Fab Light Chain 9606
224 6AZ2 3 E, F Fab Light Chain 9606
225 1CZ8 2 L, X LIGHT CHAIN OF NEUTRALIZING ANTIBODY MUTATED FORM OF A HUMANIZED MURINE ANTIBODY LIGHT CHAIN 10090
226 4XAK 3 E, L Light chain of neutralizing antibody m336 9606
227 5JQ6 3 L Tefibazumab FAB FRAGMENT LIGHT CHAIN 10090
228 6DF2 1 A, L Anti-phosphotyrosine antibody c310-4D5 heavy chain 32630
229 3HR5 1 A, L, P, Q Fab h47H4 light chain 10090
230 6AL4 1 A, C, E B43 LIGHT CHAIN 9606
231 4EDW 2 L tanezumab Fab light chain 9606
232 1FVE 1 A, C IGG1-KAPPA 4D5 FAB (LIGHT CHAIN) 9606
233 4NM4 1 L, M Antibody CR8043, Light Chain 9606
234 2H9G 1 A, L Fab BdF1, light chain Fab fragment 9606
235 4G7V 2 L fragment antibody light chain 9606
236 4HFW 1 A, L 6-26 Fab Light chain 9606
237 3L7E 1 A, L C836 LIGHT CHAIN CHIMERIC MOLECULE OF MOUSE VARIABLE DOMAIN AND HUMAN CONSTANT DOMAIN 10090
238 2XRA 3 L HK20, HUMAN MONOCLONAL ANTIBODY LIGHT CHAIN 9606
239 4LIQ 3 L Fab fragment RG7155 light chain Humanized Version of a monoclonal murine. 10090
240 5JO4 4 D G6 Fab Light Chain 9606
241 3INU 2 L, N KZ52 antibody fragment light chain 9606
242 5EU7 3 C, D FAB light chain 9606
243 1DFB 1 L IGG1-KAPPA 3D6 FAB (LIGHT CHAIN) 9606
244 1AD0 1 A, C ANTIBODY A5B7 (LIGHT CHAIN) FAB FRAGMENT 9606
245 4U6V 2 L, M Fab, antigen binding fragment, light chain 9606
246 2XA8 2 L OMALIZUMAB LIGHT CHAIN 9606
247 3EYV 1 A, L hu3S193 Fab, light chain 10090
248 5IJK 3 C, D 1E03 Fab fragment light chain 9606
249 3BDY 2 L Fab Fragment -Light Chain 9606
250 5I8E 2 B, D VRC34.01 Fab light chain 9606
251 3FZU 1 D, L immunoglobulin IgG1 Fab, light chain 9606
252 5UIX 2 L DH576 Fab light chain 9606
253 3K2U 4 L Antibody, Fab fragment, Light Chain 9606
254 5VSH 2 B, D, F, L CH1/Clambda Fab light chain 9606
255 1PG7 2 L, M humanized antibody D3H44 antigen-binding fragment 10090
256 2HFG 1 L CB3s Fab light chain (kappa) 9606
257 3GKW 2 L Light chain of the antibody Nimotuzumab 9606
258 3JWD 3 L, O FAB 48D LIGHT CHAIN 9606
259 5ZIA 2 B, E, I, L, M, P Light chain (kappa) of CBTAU-24.1 antibody 9606
260 4JQI 3 L Fab30 light chain 10090
261 6B0H 3 A, C 1262 antibody, light chain 9606
262 3SKJ 1 L, M Antibody, light chain 9606
263 3U30 2 B, E Light chain Fab 9606
264 6MFJ 2 B, L DH677.3 Fab light chain 9606
265 5HYS 2 B, D, F, L Uncharacterized protein 9606
266 3L7F 1 A, D, L H2L6 LIGHT CHAIN 9606
267 5I15 1 L FAB LIGHT CHAIN 9606
268 2FJF 1 A, C, E, G, J, L, M, O, Q, S, U, W Light Chain of a VEGF binding Antibody 9606
269 5I1E 1 L FAB LIGHT CHAIN 9606
270 4JLR 2 B, L Motavizumab Fab light chain 9606
271 2QQK 3 L Antibody Light Chain 9606
272 4J1U 1 A, C, E antibody 93F3 Light chain 10090
273 4RRP 1 A, B, C, D, E, F Fab antibody, light chain 9606
274 5SX5 1 K, L Panitumumab Fab Light Chain 9606
275 4XGZ 2 B, D, F, I, K, L, N, P, R, T, V, X FAB LIGHT CHAIN 9606
276 1N8Z 1 A Herceptin Fab (antibody) - light chain 10090
277 4OAW 1 A, C Light chain of Fab fragment of anti-HIV1 gp120 V2 mAb 2158 9606
278 5BK2 3 D, L sAB Light Chain 9606
279 1TZH 2 A, L Fab YADS1 Light Chain 10090
280 5O1R 3 L, M Uncharacterized protein 9606
281 4JZJ 3 B, L Fab Light Chain 10090
282 5BO1 3 L, M Fab light chain 9606
283 6FOE 2 B, L Fab BaxB01 light chain engineered Fab light chain binds oxidized macrophage migration inhibitory factor (MIF) 9606
284 4M6O 1 L CNTO7309 light chain 9606
285 5LSP 3 L, T 107_A07 Fab light chain 9606
286 6MWN 3 D, L Fab HAVx Light Chain 9606
287 4DVR 2 L Fab 48d Light chain 9606
288 6PI7 2 B, E Uncharacterized protein 9606
289 5BK3 1 B, D, F, L 580 Antibody, light chain 9606
290 6HXW 3 D, L IPH53 light chain 32630
291 4XWO 3 D, F, J, L, P, R, V, X Antibody light chain 32630
292 4ZFF 2 B, L Fragment antigen binding (Fab) 5A12 Light chain 9606
293 3HI5 2 L light chain of Fab fragment of AL-57 against alpha L I domain 9606
294 6BGT 2 A Herceptin light chain mutant 9606
295 5FUZ 2 L 645 FAB, LIGHT CHAIN 9606
296 3DVG 1 A Human IgG1 fab fragment light chain 9606
297 4HS8 3 L antibody hu5B3.v2 Fab light chain 9606
298 1B6D 1 A, B IMMUNOGLOBULIN IMMUNOGLOBULIN LIGHT-CHAIN DIMER 9606
299 3NFS 1 L Heavy chain of Fab fragment of daclizumab 9606
300 2FGW 1 L H52 FAB (LIGHT CHAIN) 9606
301 1B2W 1 L PROTEIN (ANTIBODY (LIGHT CHAIN)) V DOMAIN AND C DOMAIN 10090
302 2FJG 2 A, L Fab light chain 9606
303 4DKF 3 L, M FAb2 Light Chain 9606
304 5TLK 3 C, G H2191 LIGHT CHAIN 10090
305 6OGX 2 D Fab1 Light Chain 9606
306 6OGX 5 L Fab2 light chain 9606
307 1HEZ 1 A, C KAPPA LIGHT CHAIN OF IG 1-214 9606
308 6MEJ 5 L antibody HEPC3 Light Chain 9606
309 3EFD 1 L FabL 10090
310 4LF3 1 A, D Fab heavy chain 10090
311 6IAP 2 D Fab NKp46-4 light chain 32630
312 6IAP 5 L Fab NKp46-1 light chain 32630
313 5K59 4 F, L Fab light chain 9606
314 6MUB 1 K, L Fab 2G12, light chain 9606
315 6BFQ 2 B, D, F, L Fab Light Chain 9606
316 5KN5 2 B, E Epiregulin Antibody LY3016859 Fab Light Chain 9606
317 6O3B 1 A, E Antibody Fab F6, Light chain 9606
318 5F3H 2 B, D, F, H humanized RK35 antibody light chain 10090
319 4LEO 2 B RG7116 Fab light chain 10090
320 4G7Y 2 L Fragment antibody light chain 9606
321 4PY8 4 J antibody 3.1 light chain Fab 9606
322 3DVN 1 A, L Human IgG1 fab fragment light chain 9606
323 3IXT 1 B, L Motavizumab Fab light chain 10090
324 3UC0 3 L, M Light chain, monoclonal antibody 5H2 Fab 9598
325 1BBJ 1 A, L IGG4-KAPPA B72.3 FAB (LIGHT CHAIN) 10090
326 5I1I 1 L FAB LIGHT CHAIN 9606
327 4NNP 3 L, Y Light chain of antagonistic fab fragment 9606
328 4ERS 1 L Fab light chain 9606
329 1DEE 1 A, C, E IGM RF 2A2 FAB LIGHT CHAIN 9606
330 2WUC 5 L FAB FRAGMENT FAB40.DELTATRP LIGHT CHAIN 9606
331 3SQO 3 L J16 Light chain 9606
332 4K3J 4 L Onartuzumab Fab light chain 10090
333 6PE8 2 B, L FAB Light chain 9606
334 6CYF 2 C, E, L, T IgG1 antibody, kappa light chain 9606
335 6MNF 1 K, L Fab 2G12, light chain 9606
336 4PY7 2 B, J antibody 3.1 light chain Fab 9606
337 6AL5 2 L B43 LIGHT CHAIN 9606
338 4K8R 3 C Fab1, light chain 9606
339 6HHC 1 L FXIA ANTIBODY FAB LIGHT CHAIN 9606
340 6ML8 4 L C05 antibody Fab light chain 9606
341 1TZI 1 A Fab YADS2 Light Chain 10090
342 4KUZ 1 L antibody 4A5 light chain Fab (mouse variable domain, human constant domain) 10090
343 4X7T 2 B, L Omalizumab-Fab Light chain 9606
344 4YK4 1 B, Y 641 I-9 VLCL antibody 9606
345 2QSC 1 L Fab F425-B4e8, Light chain Light chain 9606
346 1MHP 3 L, Y FAB FRAGMENT, light chain 10090
347 4N9G 2 B, F, L, N Antibody 17HD9, Light Chain 9544
348 6MEI 3 L antibody HEPC3 Light Chain 9606
349 3R1G 3 L FAB of YW412.8.31 antibody light chain 9606
350 2QQL 3 L Antibody Light Chain 9606
351 4MXV 2 E, L, X anti-Lymphotoxin alpha antibody light chain Fab 9606
352 5SX4 1 I, L Panitumumab Fab Light Chain 9606
353 3WD5 2 L Adalimumab Light Chain 9606
354 3EOA 1 A, L Efalizumab Fab fragment, light chain 9606
355 5GZO 3 D, L Antibody light chain 9606
356 2WUB 4 L, Q FAB FRAGMENT FAB40.DELTATRP LIGHT CHAIN 9606
357 4KY1 1 L IMMUNOGLOBULIN IGG1 FAB, LIGHT CHAIN muHP1/2 CDRs + human kappa B3 germline VL framework 9606
358 4FP8 3 L, M, N, O Antibody C05, light chain 9606
359 6R2S 1 A Antibody DB9 light chain 9606
360 6I8S 3 I, J, K, L LIGHT CHAIN OF FAB FRAGMENT FROM AN PAI-1 ANTIBODY FAB FRAGMENT 562
361 6CW2 4 B antibody light chain 9606
362 3BE1 3 L Fab Fragment-Light Chain 9606
363 2FJH 2 A, L Fab fragment light chain 9606
364 5XEZ 3 D, L Antibody, mAb1, light chain 9606
365 4K9E 1 L light chain 10090
366 3P0V 1 L, M Fab DL11 light chain 9606
367 2OQJ 1 A, D, G, J Fab 2G12 light chain 9606
368 6OEL 5 L engineered Fab light chain 9606
369 5VIG 2 B, L Fab light chain 9606
370 3HMX 3 L USTEKINUMAB FAB LIGHT CHAIN 9606
371 6I04 3 D, L Fab light chain 9606
372 5VYF 1 A, L Antibody light chain 10090
373 4K7P 1 X antibody rhumAb6 Fab fragment light chain Fab rhumAb6 9606
374 4K7P 4 L antibody 10C4 Fab fragment light chain 10090
375 5WUX 2 B, D, L light 9606
376 3OB0 1 K, L Fab 2G12, light chain Fab 9606
377 6MFP 4 D, L DH677.3 Fab light chain 9606
378 1T04 1 A, C Huzaf Antibody Light Chain The source is engineered human constant and framework regions with CDRs from mouse. 9606
379 6GK7 1 L HUMAN FAB ANTIBODY FRAGMENT OF CBTAU-27.1(S31Y,T100I) FAB ANTIBODY FRAGMENT 9606
380 3ZTN 4 L FI6V3 ANTIBODY LIGHT CHAIN 9606
381 4I18 1 B, L antibody light chain Fab 10090
382 4Q9R 2 L Fab BL3-6, LIGHT CHAIN 10090
383 3IDY 3 C, L Fab b13 light chain 9606
384 3IVK 1 B, L Fab light chain man 10090
385 5I19 1 L FAB LIGHT CHAIN 9606
386 5TH9 1 L, M, N GS-5745 Fab light chain 9986
387 6OKN 2 B, D Fab 1A7 light chain 9606
388 6OC3 2 B, D Light chain of FluA-20 Fab 9606
389 6NZ7 4 I, L 429 B01 FAB light chain 9606
390 5X8L 2 K, L, M, N, O atezolizumab light chain 9606
391 5UDC 2 C, G, L MEDI8897 Fab Light Chain 9606
392 6GK8 2 L HUMAN FAB ANTIBODY FRAGMENT OF CBTAU-28.1(S32R;E35K) FAB ANTIBODY FRAGMENT 9606
393 5FEC 2 B, L germline 3BNC60 light chain 9606
394 1RZI 1 A, C, E, G, I, K, M, O Fab 47e light chain 9606
395 2R56 2 L, M IgE Fab Fragment, light chain 9606
396 1ZA6 1 A, C, E, G IGG Light chain 9606
397 4ZS6 1 D, L fab Light Chain 9606
398 4Z5R 2 A, J, L, P, R, T, V, Y anti-IFN-a antibody rontalizumab light chain 9606
399 6APB 3 L ADI-14359 Fab Light Chain 9606
400 5CD3 2 B, D, F, H DRVIA7 Light Chain 9606
401 6D01 2 B, D, F, H 1210 Antibody, Light chain 9606
402 5CZV 3 L Fab 20350 light chain 9606
403 5XF1 3 D, L Antibody mAb1 Light chain 9606
404 4P59 3 L MOR09825 Fab fragment light chain 9606
405 5XXY 2 L light chain of atezolizumab fab 9606
406 5CJO 3 L FAB light chain 10090
407 4LMQ 3 I, L Stromal cell-derived factor 1 9606
408 3N85 2 L Fab37 Light Chain 9606
409 3G6J 3 E, G Fab light chain 9606
410 5GJT 3 L light chain of human neutralizing antibody 3E1 light chain of neutralizing antibody 3E1 9606
411 6MH2 1 A, C Herceptin Fab arm light chain 9606
412 6K7O 3 C, E, G, L h128-3 Fab light chain 9606
413 3HMW 1 L USTEKINUMAB FAB LIGHT CHAIN 9606
414 5O4G 2 A MF3958 FAB light chain 9606
415 6PE9 2 B, D, F, L, M FAB Light chain 9606
416 2QAD 3 C, G anti-HIV-1 antibody 412d light chain FAB, ANTIGEN-BINDING FRAGMENT 9606
417 4DKE 3 L, M FAb1.1 Light Chain 9606
418 5VIC 2 L Fab light chain 9606
419 6MEK 3 D, L HEPC3 Light Chain 9606
420 3NFP 2 B, L Light chain of Fab fragment of daclizumab 9606
421 1BEY 1 L CAMPATH-1H ANTIBODY FAB FRAGMENT 9606
422 5GJS 3 L light chain of human neutralizing antibody 3E1 9606
423 4NRY 1 B, L m66 Heavy Chain 9606
424 6OE4 2 C, F CR9501 Fab Light Chain 9606
425 6N2X 1 K, L Fab 2G12 light chain 9606
426 3S37 1 L 1121B Fab light chain 10090
427 5XHF 1 A, C polypeptide (L chain) 10090
428 5VL7 4 L Fab33 light chain 9606
429 1PKQ 1 A, F (8-18C5) chimeric Fab, light chain 10090
430 6DEZ 1 A, L Anti-phosphotyrosine antibody PY20-4D5 light chain 32630
431 1S78 2 C, E Pertuzumab Fab light chain 10090
432 4NYL 1 B, D, F, L Adalimumab Light Chain 9606
433 5D1Z 1 A, H Y10 Light Chain 9606
434 5D1Z 3 C, E D4-10 Light Chain 9606
435 4XHJ 3 C, G Fab-RC light chain 9606
436 5O4O 1 A MF3178 FAB light chain 9606
437 5HJ3 4 B, F, J, N KZ52 Antibody Fragment 9606
438 5D1Q 1 A D2-06 Light Chain 9606
439 1ZA3 1 A, L Fab-YSd1 light chain Fab light chain 9606
440 3UAJ 3 D, L Light chain, monoclonal antibody 5H2 Fab 9598
441 3C09 1 B, L Matuzumab Fab Light chain Human/mouse chimeric derivative of mouse monoclonal antibody 425 10090
442 5XHV 3 L, Q S40 light chain 9606
443 4IOF 3 D, F Fab-bound IDE, light chain 10090
444 5FUO 3 L FAB LIGHT CHAIN 9606
445 4JHW 2 L D25 light chain 9606
446 4HG4 4 K, M, O, Q, S, U, W, Y, z Fab 2G1 light chain 9606
447 6CXL 1 K, L anti-HIV-1 Fab 2G12 light chain 9606
448 3ZTJ 4 H, J, L FI6V3 ANTIBODY LIGHT CHAIN 9606
449 4M1C 3 D, F Fab-bound IDE, light chain 9606
450 5UQY 3 C, G, K, O MR78 Fab light chain 9606
451 6D0U 3 D, F, I, L Antibody C05, light chain 9606
452 2JIX 1 A, G, L ABT-007 FAB FRAGMENT 9606
453 3ULV 2 L Fab15 light chain 9606
454 3ULV 6 E Fab1068 light chain 9606
455 4M7L 2 L 10H10 light chain SEE REMARK 999 10090
456 4MXW 5 L, V anti-Lymphotoxin alpha antibody light chain Fab 9606
457 5UOE 3 L, N, Q, T, W FAB light chain 9606
458 5VL3 3 B, D, F, L Epratuzumab Fab Light Chain 10090
459 5JW3 4 L MEDI8852 light chain 9606
460 6D11 2 B, D 1450 Antibody, Light chain 9606
461 3S36 1 L 1121B light chain 10090
462 5CWS 1 A, G sAB-158 Fab Light Chain 9606
463 5I5K 3 L, Y Eculizumab light chain (variable domain) 9606
464 2R0K 2 L antibody light chain of Fab58 9606
465 3CSY 2 B, D, F, H Fab KZ52 light chain light chain 9606
466 5C8J 2 B, D, F, H Antibody fragment, light chain OBTAINED BY PHAGE DISPLAY FROM A LIBRARY OF HUMAN IGG. ANTIBODY FRAGMENT; THE CDRS ARE COMPLETELY SYNTHETIC 9606
467 4R4F 2 L Antibody 2.2c LIGHT CHAIN 9606
468 4G80 3 B, D, F, H fragment antibody light chain 9606
469 3JWO 3 L FAB 48D LIGHT CHAIN 9606
470 5CD5 3 D DRVIA7 Fab Light Chain 9606
471 3P11 2 L Fab DL11 light chain 9606
472 3ULU 2 L Fab15 light chain 9606
473 3ULU 6 E Fab1068 light chain 9606
474 5W1K 1 A, F, K, S CR1-28 Fab light chain 9606
475 4XI5 3 C Fab-94 light chain 9606
476 5WOB 4 J, L, N, P, R, T, V, X IDE-bound Fab light chain 60742
477 3EOB 1 A, L Efalizumab Fab fragment, light chain 9606
478 6EAY 1 L CA45 light chain 9541
479 5G64 3 L, M FAB FRAGMENT LIGHT CHAIN, RESIDUES 1-218 9606
480 4NM8 3 L, M, N Antibody CR8043, Light Chain 9606
481 5W1M 1 A, C, E, G CR1-07 Fab light chain 9606
482 6RCV 4 D, I R5.016 light chain 9606
483 5JW4 4 N, P, T, V, X MEDI8852 light chain 9606
484 5JW4 6 R MEDI8852 light chain 9606
485 2QR0 1 A, E, G, K, M, Q, S, W Fab-Fragment Light Chain 9606
486 5UDD 3 P, Q, R, S, T, U MEDI8897 Fab Light Chain 9606
487 5J3D 2 B, D, L 14N4 light chain 9606
488 4R4N 3 D, G, K, L, O, R, U, X Antibody 2.2c LIGHT CHAIN 9606
489 3EFF 1 A, C FAB 10090
490 3PJS 1 A, C FAB light chain 10090
491 6OE5 3 C Motavizumab Fab Light Chain 10090
492 6OE5 5 L CR9501 Fab Light Chain 9606
493 6MAM 2 B, D, F ADI-15946 Fab Light Chain 9606
494 5O7P 2 A MF3178 FAB light chain 9606
495 4ZYP 3 L, M, O Motavizumab antibody light chain 10090
496 4ZYP 5 E, G, I AM14 antibody light chain 9606
497 6RCU 4 D R5.016 light chain 9606
498 5DWU 4 L Fab - Light Chain 9606
499 5V2A 3 L Light chain (kappa) of H7.167 antibody Fab 9606
500 6EA7 4 L, N, R ADI-15878 Fab Light Chain 9606
501 5I8H 5 F, H VRC34.01 Fab light chain 9606
502 4FQR 4 b, d, f, h, j, l, n, p, r, t, v, x Broadly neutralizing antibody C05, light chain 9606
503 4R4H 3 L Antibody 2.2c, Light chain 9606
504 6EA5 4 L, N, R ADI-15878 Fab Light Chain 9606
505 5FHC 5 L Antibody 114 Fab light chain 9606
506 4XMN 6 L Antibody 87 light chain 32630
507 4XMM 8 L Antibody 57 light chain 9606
508 4NHH 1 F, G, K, L, P, Q 2G12 IgG dimer light chain 9606
509 4NHG 2 B, C, F, G, K, L 2G12 IgG dimer light chain 9606
510 6OT0 5 L Fab light chain 10090
511 6OGE 2 B Pertuzumab FAB LIGHT CHAIN 9606
512 6OGE 4 D Trastuzumab FAB LIGHT CHAIN 9606
513 6QD8 1 L, Y, Z Light chain 9606
514 6NC3 4 L, T, U, V, W, X Monoclonal antibody VRC34.01 fragment antigen binding light chain 9606
515 6MLM 4 G, I, L Light chain Fv of H7.5 Fab 9606
516 6MJZ 3 L PIA174 Fab Light chain 9606
517 6E5P 1 1, 4, K, L, Q, T 2G12 Light chain 9606
518 6E1K 2 C, E cat06 light chain 9606
519 6CMO 5 L Fab light chain 32630
520 6BF7 3 D, F Fab H11-E light chain 10090
521 6BF9 3 D, F Fab H11-E light chain 10090
522 6B7Z 3 D, F FAB H11 light chain 10090
523 6B70 3 D, F FAB H11-E light chain 10090
524 3J70 2 B, N, S monoclonal antibody 17b heavy chain 9606
525 3CM9 3 L, M, N, O Ig alpha-2 chain C region 9606
526 3CHN 1 L, M, N, O Immunoglobulin kappa light chain 9606
527 2QTJ 1 L, M, N, O Kappa light chain IgA1 9606
528 2ESG 1 L, M Immunoglobulin A1 light chain 9606
529 1R70 1 A, C Human IgA2(m1) Light Chain 9606
530 1IGA 2 C, D IGA1 CHAINS A AND B, HEAVY, CHAINS C AND D, LIGHT 9606